About Nuclear Imaging Nuclear imaging is a branch of medical imaging which uses small amounts of radioactive tracers to diagnose, to determine severity of the disease, and treat various chronic disorders such as cancers, cardiac diseases, gastrointestinal and neurological abnormalities. PET nuclear imaging has multiple applications in clinical neurology, includes epilepsy, movement disorders, brain tumors, dementia, neuronal plasticity, and stroke. Also, it is used to diagnose oncology, cardiology (has some limited applications), and other neurodegenerative disorders. However, the majority of PET scans are used to diagnose and treat cancers. The radioactive tracers concentrate in the regions of cancer, which are detected by the PET nuclear imaging. Technavio’s analysts forecast the global nuclear imaging market to grow at a CAGR of 6.01% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global nuclear imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated form the new nuclear imaging equipment sales. The market is divided into the following segments... Research Beam Model: Research Beam Product ID: 1935130 3500 USD New
Global Nuclear Imaging Market 2017-2021
 
 

Global Nuclear Imaging Market 2017-2021

  • Category : Healthcare
  • Published On : August   2017
  • Pages : 117
  • Publisher : Technavio
 
 
 
About Nuclear Imaging
Nuclear imaging is a branch of medical imaging which uses small amounts of radioactive tracers to diagnose, to determine severity of the disease, and treat various chronic disorders such as cancers, cardiac diseases, gastrointestinal and neurological abnormalities. PET nuclear imaging has multiple applications in clinical neurology, includes epilepsy, movement disorders, brain tumors, dementia, neuronal plasticity, and stroke. Also, it is used to diagnose oncology, cardiology (has some limited applications), and other neurodegenerative disorders. However, the majority of PET scans are used to diagnose and treat cancers. The radioactive tracers concentrate in the regions of cancer, which are detected by the PET nuclear imaging.

Technavio’s analysts forecast the global nuclear imaging market to grow at a CAGR of 6.01% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global nuclear imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated form the new nuclear imaging equipment sales.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• GE Healthcare,
• Siemens Healthcare,
• Koninklijke Philips,
• Digirad
• Mediso Medical Imaging Systems
Other prominent vendors
• Advanced Accelerator Applications
• Agfa-Gevaert
• BC Technical
• CardiArc
• Cardinal Health
• Carestream Health
• CMR Naviscan
• Cubresa
• DDD-Diagnostic
• Eczacibasi-Monrol Nuclear Products
• FMI Medical Systems
• FUJIFILM Holdings
• MiE America
• MILabs
• NeuroLogica
• Neusoft Medical Systems
• Photo Diagnostic Systems
• RadioMedix
• Sofie Biosciences
• Spectrum Dynamics Medical
• SynchroPET
• Toshiba Medical Systems
Market driver
• Increasing prevalence of chronic diseases
• For a full, detailed list, view our report

Market challenge
• Risks and safety issues associated with nuclear imaging and radiation exposure
• For a full, detailed list, view our report

Market trend
• Growing focus on developing PET/MRI hybrid imaging systems
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by application
• Oncology
• Cardiology
• Neurology
• Others
PART 07: Market segmentation by product
• Standalone PET nuclear imaging
• Standalone SPECT nuclear imaging
• Hybrid nuclear imaging
PART 08: Market segmentation by end-user
• Hospitals
• Diagnostic centers
• Research centers
PART 09: Geographical segmentation
• Nuclear imaging market in Americas
• Nuclear imaging market in EMEA
• Nuclear imaging market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Market challenges
PART 12: Market trends
• Emergence of time of flight (TOF) nuclear imaging systems
• Growing focus on developing PET/MRI hybrid imaging systems
• Vendors' focus on emerging economies
• Growing focus on cyclotron-based production
• Advances in radionanomedicine
PART 13: Vendor landscape
• Competitive scenario
• Key news
PART 14: Key vendor analysis
• Digirad
• GE Healthcare
• Mediso
• Koninklijke Philips
• Siemens Healthcare
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global nuclear imaging market 2016-2021 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: Global nuclear imaging market by application 2016 (%)
Exhibit 04: Global nuclear imaging market by product 2016 ($ millions)
Exhibit 05: Global nuclear imaging market by product 2016-2021 ($ millions)
Exhibit 06: Global nuclear imaging market by product 2016-2021 (%)
Exhibit 07: Global nuclear imaging market by product 2016 and 2021 (%)
Exhibit 08: Global nuclear imaging market by product 2016 and 2021 ($ millions)
Exhibit 09: Global nuclear imaging market by product 2016 (%)
Exhibit 10: Nuclear imaging market by product type 2016
Exhibit 11: Snapshot of global PET nuclear imaging market 2016
Exhibit 12: Global standalone PET nuclear imaging market 2016-2021 ($ millions)
Exhibit 13: Snapshot of global SPECT nuclear imaging market 2016
Exhibit 14: Global standalone SPECT nuclear imaging market 2016-2021 ($ millions)
Exhibit 15: Snapshot of global hybrid nuclear imaging market 2016
Exhibit 16: Global hybrid nuclear imaging market 2016-2021 ($ millions)
Exhibit 17: Global nuclear imaging market by end-users 2016 (%)
Exhibit 18: Global nuclear imaging market by geography 2016
Exhibit 19: Global nuclear imaging market by geography 2016-2021 ($ millions)
Exhibit 20: Global nuclear imaging market by geography 2016-2021 (%)
Exhibit 21: Global nuclear imaging market by geography 2016 and 2021 ($ millions)
Exhibit 22: Global nuclear imaging market by geography 2016 and 2021 (%)
Exhibit 23: Nuclear imaging market in Americas 2016-2021 ($ millions)
Exhibit 24: Nuclear imaging market in EMEA 2016-2021 ($ millions)
Exhibit 25: Nuclear imaging market in APAC 2016-2021 ($ millions)
Exhibit 26: Advantages of cyclotron-based radioisotopes production
Exhibit 27: Competitive structure analysis of global nuclear imaging market 2016
Exhibit 28: Digirad: Key highlights
Exhibit 29: Digirad: Strength assessment
Exhibit 30: Digirad: Strategy assessment
Exhibit 31: Digirad: Opportunity assessment
Exhibit 32: GE Healthcare: Key highlights
Exhibit 33: GE Healthcare strength assessment
Exhibit 34: GE Healthcare strategy assessment
Exhibit 35: GE Healthcare opportunity assessment
Exhibit 36: Mediso: Key highlights
Exhibit 37: Mediso: Strength assessment
Exhibit 38: Mediso: Strategy assessment
Exhibit 39: Mediso: Opportunity assessment
Exhibit 40: Koninklijke Philips: Key highlights
Exhibit 41: Koninklijke Philips: Strength assessment
Exhibit 42: Koninklijke Philips: Strategy assessment
Exhibit 43: Koninklijke Philips: Opportunity assessment
Exhibit 44: Siemens Healthcare: Key highlights
Exhibit 45: Siemens Healthcare: Strength assessment
Exhibit 46: Siemens Healthcare: Strategy assessment
Exhibit 47: Siemens Healthcare: Opportunity assessment
?

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT